Publications by authors named "Erden Banoglu"

Claim this Profile
E
Enhanced Efficiency of the Microsomal Prostaglandin E Synthase-1 Inhibitor AGU661 in Human Whole Blood by Encapsulation into PLGA-Based Nanoparticles.
Philipp Dahlke, Paul M Jordan, Lea C Klepsch, Azize Gizem Ergül, Steffi Stumpf, Erden Banoglu

Mol Pharm· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harnessing structure-activity relationships to repurpose the FLAP inhibitor BRP-7 into potent and selective sEH inhibitors.
Kübra Çalışkan, Mehmet Karataş, Paul M Jordan, Burcu Çalışkan, Oliver Werz, Erden Banoglu

Bioorg Chem· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent soluble epoxide hydrolase inhibitors based on thiazole-5-carboxamide structure with imidazolidinone moiety as a secondary pharmacophore.
Deniz Lengerli, Beyzanur Koç, Paul M Jordan, Kübra Çalışkan, Burcu Çalışkan, Erden Banoglu

Bioorg Chem· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenyl-benzyl-ureas with pyridazinone motif: Potent soluble epoxide hydrolase inhibitors with enhanced pharmacokinetics and efficacy in a paclitaxel-induced neuropathic pain model.
Deniz Lengerli, Arooj Bakht, Kübra Çalışkan, Philipp Dahlke, Nur Banu Bal, Erden Banoglu

Eur J Med Chem· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of novel microsomal prostaglandin E synthase 1 (mPGES-1) inhibitors by a structurally inspired virtual screening study.
Abdurrahman Olğaç, Paul M Jordan, Christian Kretzer, Oliver Werz, Erden Banoglu

J Mol Graph Model· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isoxazole-pyrimidine derivatives as TACC3 inhibitors: A novel modality to targeted cancer therapy.
Deniz Lengerli, Özge Akbulut Çalışkan, Kübra Çalışkan, Özge Saatci, Chaemin Lim, Erden Banoglu

Bioorg Chem· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-Phenylbenzothiazoles featuring heteroaryl sulfonamide end-capping substructures as developable mPGES-1 inhibitors.
Tansu Yalçın, Paul M Jordan, Abdurrahman Olğaç, Philipp Dahlke, Tuğçe Gür Maz, Erden Banoglu

Arch Pharm (Weinheim)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Benzimidazole Derivatives as Potent Inhibitors of Microsomal Prostaglandin E Synthase 1 for the Potential Treatment of Inflammation, Pain, and Fever.
Azize Gizem Ergül, Paul M Jordan, Philipp Dahlke, Nur Banu Bal, Abdurrahman Olğaç, Erden Banoglu

J Med Chem· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tirbanibulin (KX2-391) analog KX2-361 inhibits botulinum neurotoxin serotype A mediated SNAP-25 cleavage in pre- and post-intoxication models in cells.
Dilara Koc, Kubra Ibis, Peri Besarat, Erden Banoglu, Erkan Kiris

Drug Dev Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel 1,3,4-oxadiazole derivatives as highly potent microsomal prostaglandin E synthase-1 (mPGES-1) inhibitors.
Tuğçe Gür Maz, Philipp Dahlke, Azize Gizem Ergül, Abdurrahman Olğaç, Paul M Jordan, Erden Banoglu

Bioorg Chem· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer.
Mustafa Emre Gedik, Ozge Saatci, Nathaniel Oberholtzer, Meral Uner, Ozge Akbulut Caliskan, Erden Banoglu

Cancer Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Encapsulation of the dual FLAP/mPEGS‑1 inhibitor BRP‑187 into acetalated dextran and PLGA nanoparticles improves its cellular bioactivity.
Blerina Shkodra, Christian Kretzer, Paul M Jordan, Paul Klemm, Andreas Koeberle, Erden Banoglu

J Nanobiotechnology· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reviving immunogenic cell death upon targeting TACC3 enhances T-DM1 response in HER2-positive breast cancer.
Mustafa Emre Gedik, Ozge Saatci, Nathaniel Oberholtzer, Meral Uner, Ozge Akbulut, Erden Banoglu

bioRxiv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Substituted 1,2,4-Triazoles as Novel and Selective Inhibitors of Leukotriene Biosynthesis Targeting 5-Lipoxygenase-Activating Protein.
Abdurrahman Olğaç, İrfan Çapan, Philipp Dahlke, Paul M Jordan, Oliver Werz, Erden Banoglu

ACS Omega· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification.
Ozge Saatci, Ozge Akbulut, Metin Cetin, Vitali Sikirzhytski, Meral Uner, Erden Banoglu

Cell Death Differ· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benzoxazolone-5-Urea Derivatives as Human Soluble Epoxide Hydrolase (sEH) Inhibitors.
Tugce Gur Maz, Beyzanur Koc, Paul M Jordan, Kübra İbiş, Burcu Çalışkan, Erden Banoglu

ACS Omega· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 1,2,3-triazole 'all-in-one' ring system in drug discovery: a good bioisostere, a good pharmacophore, a good linker, and a versatile synthetic tool.
Deniz Lengerli, Kübra Ibis, Yahya Nural, Erden Banoglu

Expert Opin Drug Discov· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vicinal Diaryl-Substituted Isoxazole and Pyrazole Derivatives with Growth Inhibitory and Antitumor Activity.
Sümeyye Turanlı, Esra Nalbat, Deniz Lengerli, Kübra İbiş, Sezen Güntekin Ergün, Erden Banoglu

ACS Omega· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quinazoline-4(3)-one-7-carboxamide Derivatives as Human Soluble Epoxide Hydrolase Inhibitors with Developable 5-Lipoxygenase Activating Protein Inhibition.
Sümeyye Turanlı, Azize Gizem Ergül, Paul M Jordan, Abdurrahman Olğaç, Burcu Çalışkan, Erden Banoglu

ACS Omega· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and molecular modeling studies of new thiadiazole piperazine urea derivatives as potential fatty acid amide hydrolase inhibitors.
Tugce Gur Maz, Sumeyye Turanlı, H Burak Caliskan, Burcu Çalışkan, Erden Banoglu

Arch Pharm (Weinheim)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and Optimization of Piperazine Urea Derivatives as Soluble Epoxide Hydrolase (sEH) Inhibitors.
İrfan Çapan, Paul M Jordan, Abdurrahman Olğaç, Burcu Çalışkan, Christian Kretzer, Erden Banoglu

ChemMedChem· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Series of Thiadiazolyl-Benzenesulfonamides Incorporating an Aromatic Tail as Isoform-Selective, Potent Carbonic Anhydrase II/XII Inhibitors.
Erden Banoglu, Taner Ercanlı, Tuğçe Gür Maz, Daniela Vullo, Alessandro Bonardi

ChemMedChem· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel potent benzimidazole-based microsomal prostaglandin E synthase-1 (mPGES-1) inhibitors derived from BRP-201 that also inhibit leukotriene C synthase.
Azize Gizem Ergül, Tuğçe Gür Maz, Christian Kretzer, Abdurrahman Olğaç, Paul M Jordan, Erden Banoglu

Eur J Med Chem· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shifting the Biosynthesis of Leukotrienes Toward Specialized Pro-Resolving Mediators by the 5-Lipoxygenase-Activating Protein (FLAP) Antagonist BRP-201.
Christian Kretzer, Paul M Jordan, Rossella Bilancia, Antonietta Rossi, Tuğçe Gür Maz, Erden Banoglu

J Inflamm Res· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ethoxy acetalated dextran-based nanocarriers accomplish efficient inhibition of leukotriene formation by a novel FLAP antagonist in human leukocytes and blood.
Christian Kretzer, Blerina Shkodra, Paul Klemm, Paul M Jordan, Daniel Schröder, Erden Banoglu

Cell Mol Life Sci· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis